Caitlin Sheetz, MPH
Head of SAVEs
Unlock a clearer view of Medicare Part B drug and services trends with timely, accurate data on utilization, reimbursement, and patient out-of-pocket costs. Gain near-real-time insights into spending and wastage dynamics, site-of-service patterns, and specialty-level utilization to make faster, more informed decisions that impact your business.
![]()
![]()
Caitlin Sheetz, MPH
Head of SAVEs
With advanced analytics, we’re not only helping our clients at the intersection of business, policy, and strategy, but now we are helping them to redefine their role within it. Through ADVI Databoard, our clients are shaping access and pricing strategies, and harnessing the data to sharpen their competitive edge and strengthen their story.
ADVI offers three Databoard options that provide a powerful lens into the broader clinical market—enabling robust market basket analysis, head-to-head comparisons, and more accurate sales forecasting based on real-world use patterns. By integrating claim volume with payment amounts, the tool also helps illustrate how reimbursement changes affect provider behavior over time. From monitoring site-of-service shifts and specialty-level utilization to understanding discarded unit dynamics, this solution supports smarter decision-making across product strategy, policy planning, and field engagement.
These datasets provide unsurpassed benefits including:
Access Medicare Part B drug utilization and spending data with only a one-quarter lag—compared to CMS’s typical two-year delay.
Track competitor product volume, including new-to-market drugs to stay ahead of market shifts.
Prioritize research and strategic planning based on emerging trends in drug utilization.
Leverage the only comprehensive, 100% Part B services dashboard available—data not published by CMS in a single file.
Monitor real-time trends with quarterly updates that support agile decision-making.
Identify underutilized treatments and resource gaps to inform outreach and access strategies
Whether you’re tracking your own drug’s performance or benchmarking against competitors, the dashboard delivers visibility into market share, discarded units, and shifts in care delivery that traditional data sources often miss.
ADVI Databoards empower pharmaceutical manufacturers, device companies, and healthcare stakeholders with actionable intelligence drawn from near-real-time Medicare FFS data. Designed to uncover trends in utilization, reimbursement, and patient out-of-pocket costs, these tools help organizations sharpen their strategic planning, pricing models, and market assessments.
Improve understanding of Part B drug trends with timely and accurate utilization, reimbursement, and patient OOP data.
Uncover near-real-time Medicare Part B drug wastage spending dynamics impacting your business.
Improve timely access with enhanced drilldowns to understand Medicare Part B services site of service trends and specialty level utilization
Connect with our team leader:
Head of SAVEs